Presentation is loading. Please wait.

Presentation is loading. Please wait.

CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study  Fabien.

Published byErol Volkan Ağa Modified over 5 years ago

Similar presentations

Presentation on theme: "CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study  Fabien."— Presentation transcript:

1 CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study  Fabien Touzot, MD, PhD, Bénédicte Neven, MD, PhD, Liliane Dal-Cortivo, MD, Aurélie Gabrion, MSc, Despina Moshous, MD, PhD, Guilhem Cros, MD, Maryline Chomton, MD, Jean-Marc Luby, PGDipMLSc, Brigitte Terniaux, PGDipMLSc, Jérémy Magalon, PharmD, MSc, Capucine Picard, MD, PhD, Stéphane Blanche, MD, Alain Fischer, MD, PhD, Marina Cavazzana, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 5, Pages e3 (May 2015) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Scheme of the CD45RA depletion process. The BM sample undergoes 2 selection steps. First, in vitro T-lymphocyte depletion of BM was performed with a CD34+ immunomagnetic CliniMACS system (Miltenyi Biotec). The negative fraction was then CD45RA+ depleted with a CD45RA CliniMACS kit. The final cell therapy product consists of the CD34+ and CD34−CD45RA− negative fractions. Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 T-cell reconstitution after HSCT with a CD45RA-depleted allograft (patients P2, P3, and P5). A, Absolute CD3+ lymphocyte counts in peripheral blood of patients at 3, 6, 9, and 12 months and at last follow-up. B, Absolute CD3+CD4+ lymphocyte counts in peripheral blood of patients at 3, 6, 9, and 12 months and at last follow-up. C, Absolute CD3+CD8+ lymphocyte counts in peripheral blood of patients at 3, 6, 9, and 12 months and at last follow-up. D, Percentage of CD3+CD4+ lymphocytes expressing CD45RA and the CD31 markers in peripheral blood of patients treated with a CD45RA-depleted allografts at 6, 9, and 12 months and at last follow-up. E, Percentage of CD3+CD8+ lymphocyte subsets in patients at 6, 9, and 12 months and at last follow-up. Subsets were determined according to their expression of CCR7 and CD45RA, as follows: naive cells (CCR7+CD45RA+), effector memory cells (CCR7−CD45RA−), central memory cells (CCR7+CD45RA−), and TEMRA cells (CCR7−CD45RA+). Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 B and natural killer (NK) cell reconstitution after HSCT with CD45RA depletion. A, Absolute CD19+ lymphocyte counts in peripheral blood of patients at 3, 6, 9, and 12 months and at last follow-up. B, Absolute CD3−CD16+CD56+ lymphocyte counts in peripheral blood of patients at 3, 6, 9 and 12 months and at last follow-up. Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 CMV-specific T-cell responses in patients treated with CD45RA-depleted HSCT. A, Detection of CMV-specific CD8+ T cells in patient P1 by using pentamers restricted to MHC HLA-A2 and the pp65 antigen before and after HSCT (days +10 and +37, upper panel). Detection of CMV-specific CD8+ T cells in patient P1 by using IFN-γ staining of CD8+ lymphocytes incubated in vitro with the Peptivator pp65 antigen before and after HSCT (days +10 and +37, lower panel) is also shown. Patient P1 received a DLI at day +36. B, Detection of CMV-specific CD8+ T cells in patient P3 by using pentamers restricted to MHC HLA-A1 and the p50 antigen before and after HSCT (days +21 and +39). Phenotypic analysis of CMV-specific CD8+ T cells according to CD62 ligand (CD62L) and CD45RA before and after HSCT (day +39) is also shown. Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E1 CD45RA depletion of the allograft maintains the presence of CMV-specific CD8+ T cells. CMV-specific CD8+ T cells are detected in the CD34− fraction and the CD45RA-depleted allograft at a similar frequency by using pentamers specific for HLA-A1 and the CMV p50 antigen (patient P1). Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study  Fabien."

Similar presentations

Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy  Erik Wambre, PhD, Jonathan.

Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy  Erik Wambre, PhD, Jonathan.
Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation  Rita Creidy, PharmD,

Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation  Rita Creidy, PharmD,
Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.

Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.
Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs.

Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs.
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells  Marie Bleakley,

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells  Marie Bleakley,
Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood  Glynis Frans, MPharm, Leen Moens, PhD, Heidi.

Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood  Glynis Frans, MPharm, Leen Moens, PhD, Heidi.
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency 

Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency 
Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,

Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 

Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
Immunologic defects in 22q11.2 deletion syndrome

Immunologic defects in 22q11.2 deletion syndrome
Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation  Eleonora.

Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation  Eleonora.
Timely follow-up of a GATA2 deficiency patient allows successful treatment  Sara Ciullini Mannurita, MSc, Marina Vignoli, PhD, Gloria Colarusso, MD, PhD,

Timely follow-up of a GATA2 deficiency patient allows successful treatment  Sara Ciullini Mannurita, MSc, Marina Vignoli, PhD, Gloria Colarusso, MD, PhD,
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment  Federica Cattaneo, MD, Mike.

Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment  Federica Cattaneo, MD, Mike.
T-cell regulation during viral and nonviral asthma exacerbations

T-cell regulation during viral and nonviral asthma exacerbations
Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,

Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.
Reference values for peripheral blood lymphocyte subsets of healthy children in China  Yuan Ding, MD, Lina Zhou, MS, Yu Xia, MD, Wei Wang, MS, Ying Wang,

Reference values for peripheral blood lymphocyte subsets of healthy children in China  Yuan Ding, MD, Lina Zhou, MS, Yu Xia, MD, Wei Wang, MS, Ying Wang,
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 

In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,

Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Similar presentations

Ads by Google